Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 8101-8110 of 11994

Page
per page
  1. Ac-IEPD-AFC
    A4418 Ac-IEPD-AFC
    Summary: Recognition motif for serine protease granzyme B
  2. Actinomycin D
    A4448 Actinomycin D
     53 Citation
    Summary: RNA polymerase inhibitor
      ≥62.75 mg/mL
  3. Muristerone A
    A4466 Muristerone A
    Summary: TRAIL- and hFasL-induced apoptosis inhibitor
      Soluble in DMSO
  4. HLI 373
    A4478 HLI 373
    Summary: Hdm2 ubiquitin ligase (E3) inhibitor
      <37.79 mg/mL
  5. 4-HQN
    A4524 4-HQN
    Summary: PARP inhibitor
      ≥7.4 mg/mL
  6. U0126-EtOH
    A1337 U0126-EtOH
     10 Citation
    Target: MEK
    Summary: MEK1/2 inhibitor
      ≥21.33 mg/mL
  7. Daclatasvir (BMS-790052)
    A5618 Daclatasvir (BMS-790052)
    Target: HCV Proteases
    Summary: HCV NS5A inhibitor
      ≥36.6 mg/mL
  8. Crenolanib (CP-868596)
    A8307 Crenolanib (CP-868596)
     2 Citation
    Target: FLT3|PDGFR
    Summary: PDGFR-β inhibitor,potent and selective
      ≥22.2 mg/mL
  9. INCB28060
    A8448 INCB28060
     2 Citation
    Target: c-MET
    Summary: C-Met inhibitor,ATP-competitive and novel
      insoluble in EtOH; insoluble in H2O; ≥5.15 mg/mL
  10. Palomid 529
    A8618 Palomid 529
    Summary: PI3K/Akt/mTOR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥41 mg/mL

Items 8101-8110 of 11994

Page
per page